GlaxoSmithKline reported 6B in Stock for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Abbvie ABBV:US $ 3483M 355M
Alcon AG ALC:SW 1.95B 49M
Almirall ALM:SM 120M 1.4M
Amgen AMGN:US $ 4411M 325M
Bayer BAYN:GR € 10869M 445M
Biogen BIIB:US $ 1215.4M 136.1M
Bristol Myers Squibb BMY:US $ 2104M 9M
Eli Lilly And LLY:US $ 3893M 7M
Fresenius FRE:GR € 4423M 205M
Fresenius Medical Care FME:GR € 2136.96M 98.95M
Gilead Sciences GILD:US $ 2675M 1057M
GlaxoSmithKline GSK:LN 6003M 220M
GRIFOLS GRF:SM € 2124.39M 13.61M
H. Lundbeck A/S LUN:DC 3.52B 743M
Hikma Pharmaceutical HIK:LN 695M 41M
Merck MRK:GR € 4143M 243M
Merk MRK:US $ 5774M 179M
Novartis NOVN:VX SF 6997M 331M
Orion ORNBV:FH € 274.8M 9.6M
Pfizer PFE:US $ 9979M 920M
Recordati REC:IM € 256.49M 27.76M
Regeneron Pharmaceuticals REGN:US $ 1991.5M 488.7M